# Effects of dietary oyster peptide supplement on litter performance, immunological response of sows and growth performance of piglets

**Authors:** Xiaofeng Tian, Jialu Wang, Congcong Yao, Muyang Shao, Yatian Qi, Zihao Gao, Hongguo Wang, Wei Xia, Zhigang Wang, Chenyu Tao, Junjie Li

PMC · DOI: 10.3389/fvets.2025.1581041 · Frontiers in Veterinary Science · 2025-10-22

## TL;DR

This study shows that adding oyster peptides to sows' diets improves piglet health, survival, and immune response by enhancing placental nutrient transport and reducing inflammation.

## Contribution

The novel finding is that oyster peptides improve sow and piglet outcomes through specific molecular mechanisms in placental transport and inflammation.

## Key findings

- Oyster peptide supplementation increased healthy piglets and weaning survival rates.
- Oyster peptides enhanced immunoglobulin levels in colostrum and placental transporter gene expression.
- Oyster peptides reduced pro-inflammatory markers and increased anti-inflammatory and antioxidant gene levels in the placenta.

## Abstract

Animal breeding and reproduction techniques has led to an increase in the number of offspring of sows. However, weak piglets and low survival rate of piglets occurs frequently. During pregnancy, the late gestation is the most crucial period for fetal weight gain. Oyster peptides (OPI) are regarded as functional active substances derived from oysters with significant nutritional and medicinal value, exhibiting considerable potential for application. It remains unclear whether oyster peptides can play an important role in the field of sow reproduction. In this study, the objective was to investigate the impact of incorporating OPI into the diets of sows during the late gestation and lactation phases on litter performance, immunological response of sows and the growth and development of piglets.

100 sows were selected and were randomly divided into the control group (CON, basic diet) and the experimental group (OPI, supplemented with 2 mg/kg OPI in feed) with the feeding period from gestation day 90 to day 21 postpartum. First, litter performance, immunological response of sows and growth performance of piglets were analyzed; then, RNA-seq and q-PCR were used to detect the molecular mechanism of OPI.

The results demonstrated that the supplementation of OPI to the diets of sows in late gestation and lactation resulted in a significant increase in the number of healthy piglets and weaning survival rate (p ≤ 0.05); colostrum and placenta samples were collected during parturition, IgA, IgG and IgM in colostrum of sows also increased (p ≤ 0.05); expression levels of glucose transporter genes (GLUT4, SLC2A1), amino acid transporter genes (SNAT1, LAT1), and fatty acid transporter genes (FABP3) in the placenta were increased (p ≤ 0.05). The levels of pro-inflammatory factors (IL-1, IL-6, IL-8, AVPI1 were significantly decreased in the placenta, whereas the levels of anti-inflammatory factors (IL-10), antioxidant genes (SOD1, SOD2, GPX2, CAT), and anti-apoptotic genes (BCL2, BCL2L1) were sign.

## Linked entities

- **Genes:** SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517], SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513], SLC38A1 (solute carrier family 38 member 1) [NCBI Gene 81539], SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140], FABP3 (fatty acid binding protein 3) [NCBI Gene 2170], IL1A (interleukin 1 alpha) [NCBI Gene 3552], IL6 (interleukin 6) [NCBI Gene 3569], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576], AVPI1 (arginine vasopressin induced 1) [NCBI Gene 60370], IL10 (interleukin 10) [NCBI Gene 3586], SOD1 (superoxide dismutase 1) [NCBI Gene 6647], SOD2 (superoxide dismutase 2) [NCBI Gene 6648], GPX2 (glutathione peroxidase 2) [NCBI Gene 2877], CAT (catalase) [NCBI Gene 847], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BCL2L1 (BCL2 like 1) [NCBI Gene 598]
- **Species:** Sus scrofa (taxon 9823)

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, BCL2L1 (BCL2 like 1) [NCBI Gene 598] {aka BCL-XL/S, BCL2L, BCLX, Bcl-X, PPP1R52}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, SLC38A1 (solute carrier family 38 member 1) [NCBI Gene 81539] {aka ATA1, NAT2, SAT1, SNAT1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, GPX2 (glutathione peroxidase 2) [NCBI Gene 2877] {aka GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI}, CAT (catalase) [NCBI Gene 847], AVPI1 (arginine vasopressin induced 1) [NCBI Gene 60370] {aka PP5395, VIP32, VIT32}, FABP3 (fatty acid binding protein 3) [NCBI Gene 2170] {aka FABP11, H-FABP, M-FABP, MDGI, O-FABP}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}
- **Diseases:** inflammatory (MESH:D007249), OPI (MESH:C565529), gain (MESH:D015430)
- **Chemicals:** OPI (-)
- **Species:** Ostreidae (oysters, family) [taxon 6563]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12586136/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12586136/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12586136/full.md

---
Source: https://tomesphere.com/paper/PMC12586136